United States Antimony (NYSE:UAMY) Posts Quarterly Earnings Results

United States Antimony (NYSE:UAMY) released its quarterly earnings results on Thursday. The company reported ($0.06) earnings per share for the quarter, FiscalAI reports. United States Antimony had a negative return on equity of 5.29% and a negative net margin of 44.60%. The firm had revenue of $10.13 million for the quarter.

Here are the key takeaways from United States Antimony’s conference call:

• Third-quarter revenue rose 16% to $10.1 million, antimony pounds sold increased 68%, and gross profit more than doubled to $4.3 million as gross margin expanded to 42% from 23% despite lower market prices.
• The company reported a $9.5 million net loss, or $0.06 per share, with $10.3 million in operating expenses; these included exploration spending and a $3.8 million non-cash loss on its Larvotto investment.
• Management said seven DLA shipments totaling about 276,000 pounds have been accepted and paid for, and cited $48.6 million of DLA sales contracted through 2029. Full-year 2026 volume guidance is 1.68 million–1.81 million pounds of antimony, though delivery and acceptance timing remains outside the company’s control.
• The production ramp remains slower than management had expected, with prior equipment, staffing, and processing constraints at Thompson Falls; management also said Bolivia’s hydromet facility has delivered far less feedstock than planned, requiring purchases from other sources.
• The company ended September with $51 million in cash and treasuries, $39.4 million in Larvotto shares, and no borrowing against its margin line. Management said Radersburg upgrades are nearing completion and pointed to early-stage tungsten and antimony projects as potential sources of future feedstock.

United States Antimony Stock Up 3.3%

Shares of NYSE UAMY traded up $0.10 during trading on Friday, reaching $3.00. The company had a trading volume of 2,661,887 shares, compared to its average volume of 9,921,054. United States Antimony has a 12 month low of $2.53 and a 12 month high of $12.64. The stock has a market cap of $449.76 million, a P/E ratio of -23.18 and a beta of 0.49. The company’s fifty day moving average price is $3.81 and its 200-day moving average price is $6.93.

Analyst Ratings Changes

Several research firms recently commented on UAMY. Texas Capital upgraded shares of United States Antimony to a “strong-buy” rating in a research report on Wednesday, October 7th. HC Wainwright decreased their price target on shares of United States Antimony from $9.25 to $6.50 and set a “buy” rating for the company in a research report on Friday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of United States Antimony in a research report on Monday, September 14th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.75.

Key Stories Impacting United States Antimony

Here are a few of the latest stories about UAMY:

• Positive Sentiment: Q3 revenue reportedly rose 16%, indicating year-over-year sales growth. Q3 2026 earnings call highlights
• Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The new target still implies substantial upside from the reference price, though the reduction signals lower expectations. HC Wainwright stock recommendations
• Negative Sentiment: UAMY reported a Q3 loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue was $10.13 million and missed estimates, while the company also pulled guidance, adding uncertainty about its outlook. Q3 loss and revenue estimates Disappointing Q3 results and pulled guidance

Insider Buying and Selling

In other news, EVP Lloyd EVP, Chief Mining Officer, & Director bought 20,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The stock was acquired at an average price of $4.63 per share, with a total value of $92,600.00. Following the transaction, the executive vice president owned 932,881 shares of the company’s stock, valued at $4,319,239.03. This trade represents a 2.19% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary C. Evans purchased 20,000 shares of the stock in a transaction on Friday, August 28th. The shares were purchased at an average price of $4.92 per share, with a total value of $98,400.00. Following the acquisition, the chief executive officer owned 2,590,028 shares in the company, valued at approximately $12,742,937.76. The trade was a 0.78% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 62,700 shares of company stock valued at $298,592 over the last ninety days. 5.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On United States Antimony

A number of institutional investors have recently modified their holdings of the company. Global Retirement Partners LLC boosted its holdings in shares of United States Antimony by 209.7% during the 3rd quarter. Global Retirement Partners LLC now owns 58,976 shares of the company’s stock worth $246,000 after buying an additional 39,936 shares in the last quarter. Fifth Third Bancorp grew its position in shares of United States Antimony by 23.8% during the 3rd quarter. Fifth Third Bancorp now owns 494,996 shares of the company’s stock worth $2,064,000 after buying an additional 95,216 shares during the period. Inscription Capital LLC bought a new stake in United States Antimony in the third quarter valued at $47,000. Pilgrim Partners Asia Pte Ltd boosted its holdings in United States Antimony by 66.2% in the third quarter. Pilgrim Partners Asia Pte Ltd now owns 26,600 shares of the company’s stock worth $111,000 after acquiring an additional 10,600 shares in the last quarter. Finally, Axxcess Wealth Management LLC bought a new position in United States Antimony in the third quarter worth approximately $44,000. 9.49% of the stock is owned by institutional investors.

United States Antimony Company Profile

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.